Accendra Health (ACH) vs MDxHealth SA (MDXH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
MDxHealth SA (MDXH) has outperformed Accendra Health (ACH) over the past year, losing 87.2% versus a loss of 90.6%. MDxHealth SA is the larger company by market cap ($55.4 million vs $34.1 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACH | MDXH |
|---|---|---|
| Share price | $0.4432 | $0.5805 |
| Market cap | $34.08M | $55.39M |
| 1-day change | -6.28% | -3.22% |
| YTD return | -84.17% | -83.74% |
| 1-year return | -90.61% | -87.16% |
| 5-year return | -98.65% | — |
| Forward P/E | 4.86 | — |
| EPS (TTM) | $-1.44 | $-0.70 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.60 | $5.33 |
| 52-week low | $0.435 | $0.40 |
| Distance from 52-week high | -92.09% | -89.11% |
| Analyst consensus | hold | none |
| Avg. price target upside | +240.70% | +210.08% |
| Average volume | 1.40M | 5.70M |
| Shares outstanding | 76.90M | 95.42M |
| Employees | 6,500 | 364 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Distribution | Diagnostics & Research |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Accendra Health
ACH stock →Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services.
Healthcare · Medical Distribution · 6,500 employees
About MDxHealth SA
MDXH stock →MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.
Healthcare · Diagnostics & Research · 364 employees
ACH vs MDXH FAQ
Which is bigger, Accendra Health or MDxHealth SA?
MDxHealth SA (MDXH) is larger, with a market capitalization of $55.39M compared with $34.08M for Accendra Health (ACH).
Which stock has performed better over the past year, ACH or MDXH?
MDXH returned -87.16% over the past 12 months, compared with -90.61% for ACH (price return, excluding dividends). Past performance does not predict future results.
Are Accendra Health and MDxHealth SA in the same industry?
Both are in the Healthcare sector, but in different industries: Medical Distribution for Accendra Health and Diagnostics & Research for MDxHealth SA.